The RMR Group, Inc.

  • Market Cap: Micro Cap
  • Industry: Finance
  • ISIN: US74967R1068
USD
15.53
0.32 (2.1%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About The RMR Group, Inc. stock-summary
stock-summary
The RMR Group, Inc.
Finance
RMR Group Inc. is a holding company. The Company’s business is conducted by its majority owned subsidiary, The RMR Group LLC (RMR LLC). RMR LLC manages a diverse portfolio of publicly owned real estate and real estate related businesses. Its segments include RMR LLC and All Other Operations. RMR LLC provides management services to four publicly traded real estate investment trusts (REITs): Diversified Healthcare Trust (DHC), which owns medical office and life science properties, senior living communities and wellness centers; Industrial Logistics Properties Trust (ILPT), which owns and leases industrial and logistics properties; Office Properties Income Trust (OPI), which owns office properties primarily leased to single tenants and those with credit characteristics, including the government; and Service Properties Trust (SVC), which owns a diverse portfolio of hotels and net lease service and necessity-based retail properties.
Company Coordinates stock-summary
Company Details
2 Newton Pl Ste 300 , NEWTON MA : 02458-1637
stock-summary
Tel: 1 617 7968320
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 48 Schemes (41.21%)

Foreign Institutions

Held by 71 Foreign Institutions (6.52%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Adam Portnoy
President, Chief Executive Officer, Managing Director, Director
Ms. Jennifer Clark
Executive Vice President, General Counsel, Managing Director, Secretary, Director
Ms. Ann Logan
Independent Director
Mr. Rosen Plevneliev
Independent Director
Mr. Jonathan Veitch
Independent Director
Mr. Walter Watkins
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
155 Million
(Quarterly Results - Jun 2025)
Net Profit:
9 Million
stock-summary
Industry

Finance

stock-summary
Market cap

USD 543 Million (Micro Cap)

stock-summary
P/E

23.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

9.18%

stock-summary
Debt Equity

-999,999.00

stock-summary
Return on Equity

9.07%

stock-summary
Price to Book

2.35